1,169 code entries across 838 active EviCore by Evernorth policies that Backwork has recorded as requiring prior authorization. Each policy links to its page and to the payer’s source.
Summary of the payer’s published policy. Not a coverage determination — confirm with EviCore by Evernorth before submitting.
351–400 of 838, by title
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Codes requiring prior authorization |
|---|---|---|
| Imiglucerase (Cerezyme) | Jan 1, 2019 |
|
| Imiglucerase (Cerezyme) | Aug 1, 2020 |
|
| Immune Globulin Intramuscular Injection (GamaSTAN) | Jun 1, 2017 |
|---|
| Immune Globulin Intramuscular Injection (GamaSTAN) | Mar 1, 2019 |
|---|
| Immune Globulin Intramuscular Injection (GamaSTAN) | Nov 1, 2019 |
|---|
| Inclisiran Subcutaneous Injection (Leqvio) | May 1, 2022 |
|
|---|
| Inclisiran Subcutaneous Injection (Leqvio) | Apr 1, 2023 |
|
|---|
| IncobotulinumtoxinA (Xeomin) | Sep 1, 2019 |
|
|---|
| IncobotulinumtoxinA (Xeomin) | Dec 1, 2018 |
|
|---|
| IncobotulinumtoxinA (Xeomin) | Aug 1, 2022 |
|
|---|
| IncobotulinumtoxinA (Xeomin) | Oct 1, 2020 |
|
|---|
| IncobotulinumtoxinA (Xeomin) | Sep 1, 2021 |
|
|---|
| Inebilizumab-cdon (Uplizna) | Nov 1, 2020 |
|
|---|
| Inebilizumab-cdon (Uplizna) Injection | Feb 1, 2022 |
|
|---|
| Inebilizumab-cdon (Uplizna) Injection | Jan 1, 2023 |
|
|---|
| Inebilizumab-cdon (Uplizna) Injection | Oct 1, 2021 |
|
|---|
| Infliximab (Remicade, Inflectra, Renflexis, Avsola, Infliximab) Non-oncology | Dec 1, 2024 |
|
|---|
| Infliximab (Remicade, Inflectra, Renflexis, Avsola, Infliximab)_Non-onc | Sep 1, 2023 |
|
|---|
| Infliximab (Remicade, Inflectra, Renflexis, Avsola, Infliximab)_Non-oncology | Jan 1, 2024 |
|
|---|
| Infliximab (Remicade, Inflectra, Renflexis, Avsola) | Nov 1, 2022 |
|
|---|
| Infliximab (Remicade, Inflectra, Renflexis, Avsola) | Feb 1, 2021 |
|
|---|
| Infliximab (Remicade, Inflectra, Renflexis, Avsola) | May 1, 2021 |
|
|---|
| Infliximab (Remicade, Inflectra, Renflexis, Avsola) | May 1, 2022 |
|
|---|
| Infliximab (Remicade, Inflectra, Renflexis) | Oct 1, 2019 |
|
|---|
| Infliximab (Remicade, Inflectra, Renflexis) | Oct 1, 2020 |
|
|---|
| Infliximab (Remicade, Inflectra, Renflexis) | Nov 2, 2018 |
|
|---|
| Infliximab Intravenous (Remicade, Inflectra, Renflexis, Avsola, Infliximab) | Jan 1, 2026 |
|
|---|
| Injectafer (ferric carboxymaltose) | Oct 1, 2024 |
|
|---|
| Injectafer (ferric carboxymaltose) | Not recorded |
|
|---|
| Injectafer (ferric carboxymaltose) | Sep 1, 2025 |
|
|---|
| Intravenous Immune Globulins (Alyglo, Asceniv, Bivigam, Flebogamma DIF, Gammagard Liquid, Gammagard S/D, Gammaked, Gammaplex, Gamunex-C, Octagam, Panzyga, Privigen, Yimmugo) | Dec 1, 2024 |
|
|---|
| Intravenous Immune Globulins (Alyglo, Asceniv, Bivigam, Flebogamma DIF, Gammagard Liquid, Gammagard S/D, Gammaked, Gammaplex, Gamunex-C, Octagam, Panzyga, Privigen, Yimmugo) | Dec 1, 2025 |
|
|---|
| Intravenous Immune Globulins (Alyglo, Asceniv, Bivigam, Flebogamma, Gammagard Liquid, Gammagard Liquid ERC, Gammagard S/D, Gammaked, Gammaplex, Gamunex-C, Octagam, Panzyga, Privigen, Qivigy, Yimmugo) | Not recorded |
|
|---|
| Izervay (avacincaptad pegol intravitreal injection) | Jan 1, 2024 |
|
|---|
| Izervay (avacincaptad pegol intravitreal solution) | Jan 1, 2026 |
|
|---|
| Izervay (avacincaptad pegol intravitreal solution) | Jan 1, 2025 |
|
|---|
| Kalbitor (ecallantide) | Feb 1, 2024 |
|
|---|
| Kalbitor (ecallantide) | Dec 1, 2024 |
|
|---|
| Kalbitor (ecallantide) | Jan 1, 2026 |
|
|---|
| Kisunla (donanemab-azbt) | Dec 1, 2024 |
|
|---|
| Kisunla (donanemab-azbt) | Dec 1, 2025 |
|
|---|
| Kisunla (donanemab-azbt) Medicare Advantage | Jul 1, 2025 |
|
|---|
| Krystexxa (pegloticase) | Mar 1, 2024 |
|
|---|
| Krystexxa (pegloticase) | Jan 1, 2026 |
|
|---|
| Krystexxa (pegloticase) | Jan 1, 2025 |
|
|---|
| Lamzede (velmanase alfa-tycv intravenous infusion) | Aug 1, 2024 |
|
|---|
| Lamzede (velmanase alfa-tycv) | Jul 1, 2025 |
|
|---|
| Lamzede (velmanase alfa-tycv) | Aug 1, 2023 |
|
|---|
| Lamzede (velmanase alfa-tycv) | Not recorded |
|
|---|
| Lanreotide (Somatuline Depot, generic) Injection | May 1, 2025 |
|---|